Targeting DCAF5 suppresses SMARCB1-mutant cancer by stabilizing SWI/SNF
Abstract Whereas oncogenes can potentially be inhibited with small molecules, the loss of tumour suppressors is more common and is problematic because the tumour-suppressor proteins